Four Takeaways From the Year’s Biggest—and Rainiest—Healthcare Conference

Posted by Ann Klein on Thu, Jan 31, 2019

Every year in early January, Union Square in San Francisco transforms from a shopping mecca to a (usually rainy) gathering of leadership teams from payers, large providers, life sciences companies and tech companies across the globe. The visual is dramatic: You’ll never see as many dark suits in San Francisco than when you’re wandering around town during the JPMorgan Healthcare Conference.


>
Read More

What the Changes in DTC Spending Mean for Pharma Companies

Posted by Sharon Suchotliff on Mon, Nov 12, 2018

Hensley Evans co-wrote this blog post with Sharon Suchotliff. 

In our previous blog post, we shared three key trends that are driving direct-to-consumer marketing into a state of flux. These forces—the exit of big DTC spenders due to loss of exclusivity, specialty brands driving investment in TV only, and shifts in consumer behavior and marketing mix—are behind the 4.7% decline in spending that we saw between 2016 and 2017.


>
Read More

As the Goalposts Keep Moving, Pharma Can Help Providers Continue to Move the Ball Forward

Posted by Paul Darling on Mon, Nov 20, 2017

As stakeholders throughout the healthcare ecosystem continue to transition from a fee-for-service model toward value-based care—and as providers try to keep up while feeling increasingly burdened by paperwork and disconnected from patients—the Centers for Medicare & Medicaid Services (CMS) keeps moving the goalposts.


>
Read More

Highlights From ZS’s 2017 European Summit: What Industry Leaders Really Think About Patient Centricity in Pharma

Posted by Giorgio Lentini on Tue, Oct 31, 2017

Robert Selman and Ausrine Vaisvilaite co-wrote this blog post with Giorgio Lentini. 

Are we already patient-centric simply by talking about patients? Do patients define themselves by their medical conditions or by their roles in life as parents, family members or colleagues?

These were just some of the many questions discussed amongst participants at ZS’s European Summit, which took place in Basel, Switzerland, on Oct. 12.


>
Read More

How Biopharma Companies Are Working to Uncover and Meet Patient Needs

Posted by Kristyn Feldman on Wed, Oct 25, 2017

Lisa Bance co-wrote this blog post with Kristyn Feldman.

This is the second post in a four-part series examining patient centricity within R&D.

As pharmaceutical companies aim to make their drug development processes more patient-centric, we’ve noted that a formula for success is starting to emerge, and we’ve packaged that formula into our four pillars of patient centricity in R&D. In our last post, we addressed the first pillar: gaining an understanding of and empathy for patients. In this post, we review the second pillar: uncovering and meeting patients’ needs.


>
Read More